Alert detail
LCD L37863: Voretigene Neparvovec-rzyl (Luxturna®) — Palmetto GBA
What changed
Palmetto GBA finalizes Luxturna® gene therapy coverage criteria.
Who’s affected: Ophthalmology billing teams · Effective: April 20, 2023
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 10 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.